Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2002 / Cilt: 36 - Sayı: 2

Churg-Strauss syndrome: A case report

Churg-Strauss sendromlu bir olgu

Pages
132–135
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We described an ashmatic patient in whom Churg-Strauss syndrome with skin eruptions developed within six months after the withdrawal of systemic corticosteroids in association with leucocytoclastic vasculitis as well as eosinophilia, paranasal sinusitis and pulmonary infiltration.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Churg-Strauss syndrome is a rare disorder characterized by hypereosinophilia and systemic vasculitis occuring in individuals with asthma and allergic rhinitis.
📊
Key Findings & Data:Churg-Strauss syndrome is a rare disorder characterized by hypereosinophilia and systemic vasculitis occuring in individuals with asthma and allergic rhinitis.
💡
Conclusion & Impact:We described an ashmatic patient in whom Churg-Strauss syndrome with skin eruptions developed within six months after the withdrawal of systemic corticosteroids in association with leucocytoclastic vasculitis as well as eosinophilia, paranasal sinusitis and pulmonary infiltration.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Churg-Strauss syndrome is a rare disorder characterized by hypereosinophilia and systemic vasculitis occuring in individuals with asthma and allergic rhinitis. We described an ashmatic patient in whom Churg-Strauss syndrome with skin eruptions developed within six months after the withdrawal of systemic corticosteroids in association with leucocytoclastic vasculitis as well as eosinophilia, paranasal sinusitis and pulmonary infiltration.

Özet

Churg-Strauss sendromu astma ve allerjik rinitle birlikte görülen hipereozinofili ve sistemik vaskülitle karakterize nadir bir hastalıktır. Biz astma nedeniyle sistemik kortikosteroid tedavisi alan bir olguda steroid kesilmesinden yaklaşık 6 ay sonra deri döküntüleri ile başvuran ve lökositoklastik vaskülitin yanı sıra eozinofili, paranasal sinüzit ve pulmoner infiltrasyon saptanan Churg Strauss sendromlu bir olguyu sunuyoruz.

🔖

Cite This Article

ERDOĞAN, Ş. B., AKTAN, Ş., ÇOLAKOĞLU, M. (2022). Churg-Strauss syndrome: A case report. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 36 - Sayı: 2, 132–135. https://ajindex.com/articles/622257

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Mandell FM, Hoffman GS: Systemic necrotizing arteritis. Dermatology in General Medicine. Ed.Freedberg İM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB. Fifth edition. McGraw-Hill, 1999; 2038-2039
  2. Gross WL: Systemic necrotizing vasculitis. Baillere's Clinical Rheumatology 1997; 11 (2): 259-284
  3. Bamhill RL, Busam KJ: Vascular Disease. Lever's Histopatho-logy of the Skin. Ed. Elder D.Eight edition. Philedelphia New York, Lippincott-Raven Publishers, 1997; 185-208
  4. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Ca-sassus P: Churg-Strauss syndrome. Clinical study and long term follow-up of 96 patients. Medicine (Baltimore) 1999; 78(1): 26-37
  5. Hiibner C, Dietz A, Stremmel W, Stiehl A, Andrassy K: Macroli-de-induced Churg-Strauss syndrome in a patient with atopy. The Lancet 1997; 350:563
  6. Josefson D: Astma drug-linked with Churg-Strauss syndrome. BMJ 1997; 315 (9): 330
  7. Churg A, Churg J: Steroids and Churg-Strauss syndrome. The Lancet 1998; 352; 32-33
  8. Wechsler M, Drazen JM: Churg-Strauss syndrome. The Lancet 1999; 353 (5): 1970
  9. Green RL, Vayonis AG: Churg-Strauss syndrome. The Lancet 1999; 353: 1971
  10. Frosi A, Foresi A, Bozzoni M, Ubbiali A, Vezzoli F: Churg-Strauss syndrome and antiasthma therapy. The Lancet 1999; 353(27);1102
  11. Knoshj$â M, Shiraishi T, Koga T, Ayabe M, Rikimaru T, Oizumi K: Çbtrfğ-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. J Allergy Clin Immunol 1999; 103 (3) part 1: 534-535
  12. D'Cruz DP, Barnes NC, Lockwood CM: Difficult asthma or Churg-Strauss Syndrome? BMJ 1999; 318: 475-476
  13. Wechsler ME, Garpestad E, Flier SR,Kocher O, Weiland DA, Polito AJ; Klinek MM, Bigby TD, Wong GA, Helmers RA, Drazen JM: Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998; 279: 455-457
  14. Churg A, Brallas M, Cronin SR, Churg J: Formes frustes of Churg-Strauss syndrome. 1995; Chest: 108: 320-323
  15. Davis MD, Daoud MS, McEvoy MT, Su WP: Cutaneous manifestations of Churg-Strauss syndrome: A clinicopathologic correlation. J Am Acad Dermatol 1997; 37: 199-203
  16. Guillevin L, Lhote F, Gherardi R: Polyarteritis nodosa, microscopic polyarteritis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment. Neurol Clin 1997; 15(4): 865-886
  17. Worthy SA, Müller NL, Hansell DM, Flower CD: Churg-Strauss syndrome: the spect